Fasting hypertriglyceridemia in relation to mortality in an elderly male Chinese population
We investigated fasting hypertriglyceridemia as predictors of all-cause, cardiovascular, and non-cardiovascular mortality in an elderly male Chinese population, while accounting for various conventional cardiovascular risk factors. Our participants were elderly men recruited from residents living in a suburban town of Shanghai (≥60 years of age, n = 1583). Hypertriglyceridemia was defined as a fasting serum triglycerides concentration ≥1.70 mmol/L. Subgroup analyses were performed according to current smoking (yes vs. no), alcohol intake (yes vs. no), and the presence and absence of hypertension and hyperglycemia. During a median of 7.9 years follow-up, all-cause, cardiovascular, and non-cardiovascular deaths occurred in 279, 112, and 167 participants, respectively. After adjustment for confounding factors, fasting hypertriglyceridemia was not significantly (p ≥ .33) associated with the risk of all-cause, cardiovascular, and non-cardiovascular mortality. However, there was significant (p = .03) interaction between hypertriglyceridemia and the presence and absence of hypertension in relation to all-cause mortality. In normotensive, but not hypertensive individuals, hypertriglyceridemia was significantly associated with a higher risk of all-cause mortality (hazard ratio 1.57, 95% confidence interval 1.06-2.31). In further non-parametric analyses in normotensive individuals, the age-standardized rate for all-cause mortality increased from 18.9 in quartile 1 to 20.0, to 24.7, and to 39.9 per 1000 person-years in quartiles 2, 3, and 4 of serum triglycerides concentration, respectively (p<sub>trend </sub>= .0004). Similar results were observed for cardiovascular mortality. Our study in elderly male Chinese showed that fasting hypertriglyceridemia was associated with a higher risk of all-cause and cardiovascular mortality in patients with normotension but not those with hypertension.
Authors
- Chang‐Sheng Sheng (ORCID: https://orcid.org/0000-0003-2685-0663)
- Ji‐Guang Wang (ORCID: https://orcid.org/0000-0001-8511-1524)
- Xiaofei Ye (ORCID: https://orcid.org/0000-0003-3692-1285)
- Qi‐Fang Huang (ORCID: https://orcid.org/0000-0002-9780-4237)
- Yan Li (ORCID: https://orcid.org/0000-0002-5825-5968)
- Xinyu Wang (ORCID: https://orcid.org/0000-0002-9167-2077)
- Wei Zhang (ORCID: https://orcid.org/0000-0002-3614-0799)
- Wen‐Yuan‐Yue Wang
Institutions
- Shanghai Jiao Tong University (CN)
- Ruijin Hospital (CN)
- Shanghai Institute of Hypertension (CN)
Publication Details
- Journal
- Journal of Clinical Hypertension
- Published
- 2024-08-19
- DOI
- https://doi.org/10.1111/jch.14887
- Citations
- 1
- Primary Topic
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Type
- article
- Field-Weighted Citation Impact
- 0.36
Funders
- National Natural Science Foundation of China